Dr Luis A Felix, MD | |
Rd. 2 Km. 58.2 Pfizer Pharmaceuticals Llc), Barceloneta, PR 00617 | |
(787) 846-4300 | |
Not Available |
Full Name | Dr Luis A Felix |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | Rd. 2 Km. 58.2 Pfizer Pharmaceuticals Llc), Barceloneta, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235170929 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | 8092 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Luis A Felix, MD 274 Calle Canals, Suite 304, San Juan, PR 00907-3052 Ph: (787) 612-9650 | Dr Luis A Felix, MD Rd. 2 Km. 58.2 Pfizer Pharmaceuticals Llc), Barceloneta, PR 00617 Ph: (787) 846-4300 |
News Archive
Highly anticipated results from LUX-Lung 3, the pivotal Phase III lung cancer trial investigating Boehringer Ingelheim's front running oncology investigational compound, the ErbB Family Blocker afatinib, in patients with EGFR mutations, will be presented at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from 1 - 5 June 2012.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced financial results for the fourth quarter and full year ending December 31, 2013. The Company also highlighted select commercial, regulatory and clinical development progress and future goals and provided financial guidance for 2014.
For the second time in a month, a federal judge has temporarily halted a law aimed at abortion clinics. U.S. District Judge J. Thomas Marten issued a preliminary injunction Monday that blocks Kansas from stripping federal family-planning funds from Planned Parenthood. He ordered the state to start distributing the money to the agency.
A team of scientists from the National University of Singapore (NUS) has established novel insights into the relationship between breast cancer tumour intracellular redox environment and the cancer cells' ability to become invasive.
› Verified 8 days ago